Ryvu Therapeutics SA (RVU) — Cash Flow Reinvestment Rate
Ryvu Therapeutics SA (RVU) has a Cash Flow Reinvestment Rate of 3.31x as of December 2022, reinvesting zł198.08 Million (capex zł4.22 Million plus investments zł-193.87 Million) from operating cash flow of zł59.92 Million. See RVU FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Ryvu Therapeutics SA Cash Flow Reinvestment Rate (2017–2022)
Historical reinvestment intensity for Ryvu Therapeutics SA across 2 annual periods. For the full cash flow conversion analysis, see RVU cash flow metrics.
Annual Cash Flow Reinvestment Rate for Ryvu Therapeutics SA (2017–2022)
Year-by-year capital reinvestment analysis for Ryvu Therapeutics SA. See RVU free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.47x | zł9.98 Million | zł21.32 Million | zł9.29 Million | ▼ -85.8% |
| 2017 | 3.30x | zł36.26 Million | zł10.98 Million | zł21.56 Million | — |